Invention Grant
- Patent Title: Anti-human CD19 antibodies
-
Application No.: US17181184Application Date: 2021-02-22
-
Publication No.: US11623956B2Publication Date: 2023-04-11
- Inventor: Barrett Allan , Jeffrey Streetman Boyles , Alison Lee Sim Budelsky , Kira Vladimirovna Rubtsova , Guifeng Zhang , Songqing Na
- Applicant: Eli Lilly and Company
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent Dipa Patel
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K39/00 ; C12P21/06 ; C12P5/02 ; C12N5/20 ; C12N15/00 ; C07K16/00 ; C07K16/46 ; C07H21/04 ; C07K16/28 ; A61P37/06 ; A61P19/02
Abstract:
The present disclosure relates to antibodies that bind human CD19 (“anti-human CD19 antibodies” or “anti-human CD19 antibodies”), compositions comprising such anti-human CD19 antibodies, and methods of using such anti-human CD19 antibodies.
Public/Granted literature
- US20210269520A1 ANTI-HUMAN CD19 ANTIBODIES Public/Granted day:2021-09-02
Information query
